Go Back

Latest Videos

VAL-083: Dennis Brown [2022]: Key Facts To Consider Glioblastoma
VAL-083: Dennis Brown [2022]: Key Facts To Consider Gliob...
24 Views
4 days ago
Cancer News
Want to watch this again later?
Sign in to add this video to a playlist. Login
VAL-083: Dennis Brown [2022]: Key Facts To Consider Glioblastoma
VAL-083: Dennis Brown [2022]: Key Facts To Consider Gliob...
24 Views
4 days ago
Cancer News
Want to watch this again later?
Sign in to add this video to a playlist. Login
Omidubicel: Ronit Simantov Phase 3 Results [2022] Blood Cancers
Omidubicel: Ronit Simantov Phase 3 Results [2022] Blood C...
100 Views
4 days ago
Cancer News
Want to watch this again later?
Sign in to add this video to a playlist. Login
Omidubicel: Ronit Simantov Phase 3 Results [2022] Blood Cancers
Omidubicel: Ronit Simantov Phase 3 Results [2022] Blood C...
174 Views
1 week ago
Cancer News
Want to watch this again later?
Sign in to add this video to a playlist. Login
Codagenix: What is CodaLytic? Who’s the target?
Codagenix: What is CodaLytic? Who’s the target?
315 Views
2 weeks ago
Cancer News
Want to watch this again later?
Sign in to add this video to a playlist. Login
Codagenix: What is CodaLytic? Who’s the target?
Codagenix: What is CodaLytic? Who’s the target?
392 Views
2 weeks ago
Cancer News
Want to watch this again later?
Sign in to add this video to a playlist. Login
LCMC3 Neoadjuvant Atezolizumab Phase 2 Study
LCMC3 Neoadjuvant Atezolizumab Phase 2 Study
95 Views
2 weeks ago
Ohio State University CCC
Want to watch this again later?
Sign in to add this video to a playlist. Login
LCMC3 Neoadjuvant Atezolizumab Phase 2 Study
LCMC3 Neoadjuvant Atezolizumab Phase 2 Study
189 Views
2 weeks ago
Ohio State University CCC
Want to watch this again later?
Sign in to add this video to a playlist. Login
Lisocabtagene Maraleucel (Breyanzi) FDA Approval: 10 Stats
Lisocabtagene Maraleucel (Breyanzi) FDA Approval: 10 Stats
8 Views
2 weeks ago
University of Colorado Denver
Want to watch this again later?
Sign in to add this video to a playlist. Login
VS-6766 + DEFACTINIB in NSCLC KRAS: 5 Key Conclusions [2022]
VS-6766 + DEFACTINIB in NSCLC KRAS: 5 Key Conclusions [20...
6 Views
2 weeks ago
University of Colorado
Want to watch this again later?
Sign in to add this video to a playlist. Login
T-DXd Interstitial Lung Disease: Controllable? [2022]
T-DXd Interstitial Lung Disease: Controllable? [2022]
3 Views
2 weeks ago
Mount Sinai
Want to watch this again later?
Sign in to add this video to a playlist. Login
Biomarkers RNA: [2022] What Is ASPYRE Technology?
Biomarkers RNA: [2022] What Is ASPYRE Technology?
56 Views
3 weeks ago
Cancer News
Want to watch this again later?
Sign in to add this video to a playlist. Login
KRAS G12C Sotorasib: [2022] An Updated Overview in CRC
KRAS G12C Sotorasib: [2022] An Updated Overview in CRC
36 Views
3 weeks ago
City of Hope
Want to watch this again later?
Sign in to add this video to a playlist. Login
IDE196 Solid Tumors GNAQ/11 Mutations or PRKC Fusions [2022]
IDE196 Solid Tumors GNAQ/11 Mutations or PRKC Fusions [20...
13 Views
3 weeks ago
Tennessee Oncology
Want to watch this again later?
Sign in to add this video to a playlist. Login
MIRAGE Trial Phase 3: CT / MRI SBRT Which is Better? [2022]
MIRAGE Trial Phase 3: CT / MRI SBRT Which is Better? [2022]
51 Views
3 weeks ago
UCLA Health
Want to watch this again later?
Sign in to add this video to a playlist. Login
Biomarkers RNA: [2022] What Is ASPYRE Technology?
Biomarkers RNA: [2022] What Is ASPYRE Technology?
67 Views
3 weeks ago
Cancer News
Want to watch this again later?
Sign in to add this video to a playlist. Login
KRAS G12C Sotorasib: [2022] An Updated Overview in CRC
KRAS G12C Sotorasib: [2022] An Updated Overview in CRC
60 Views
3 weeks ago
City of Hope
Want to watch this again later?
Sign in to add this video to a playlist. Login
IDE196 Solid Tumors GNAQ/11 Mutations or PRKC Fusions [22]
IDE196 Solid Tumors GNAQ/11 Mutations or PRKC Fusions [22]
22 Views
3 weeks ago
Tennessee Oncology
Want to watch this again later?
Sign in to add this video to a playlist. Login
MIRAGE Trial Phase 3: CT / MRI SBRT Which is Better? [2022]
MIRAGE Trial Phase 3: CT / MRI SBRT Which is Better? [2022]
66 Views
3 weeks ago
UCLA Health
Want to watch this again later?
Sign in to add this video to a playlist. Login
7-gene DCIS: [2022] Comparing Clinicopathologic Features
7-gene DCIS: [2022] Comparing Clinicopathologic Features
10 Views
3 weeks ago
ASTRO
Want to watch this again later?
Sign in to add this video to a playlist. Login
Lung SBRT Dose Optimization [2022]: Overcoming Size & SUV?
Lung SBRT Dose Optimization [2022]: Overcoming Size & SUV?
3 Views
3 weeks ago
ASTRO
Want to watch this again later?
Sign in to add this video to a playlist. Login
7-gene DCIS [2022] Comparing Clinicopathologic Features
7-gene DCIS [2022] Comparing Clinicopathologic Features
30 Views
3 weeks ago
ASTRO
Want to watch this again later?
Sign in to add this video to a playlist. Login
Lung SBRT Dose Optimization [2022]: Overcoming Size & SUV?
Lung SBRT Dose Optimization [2022]: Overcoming Size & SUV?
10 Views
3 weeks ago
ASTRO
Want to watch this again later?
Sign in to add this video to a playlist. Login
Magrolimab + Azacitidine vs Venetoclax in AML
Magrolimab + Azacitidine vs Venetoclax in AML
3 Views
3 weeks ago
American Society of Hematology
Want to watch this again later?
Sign in to add this video to a playlist. Login